{'fraction_non_alphanumeric': 0.03219512195121951, 'fraction_numerical': 0.01024390243902439, 'mean_word_length': 5.659090909090909, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Abstracts of the 3rd Canadian Neuro-Oncology Meeting

The 3rd Canadian Neuro-Oncology Meeting was held in London, Ontario, on June 9-10, 1988. The meeting was attended by over 100 neurosurgeons, neurologists, radiation oncologists, medical oncologists, neuropathologists, neuroradiologists, scientists, oncology nurses, residents and graduate students. Fifty-five papers were presented covering a wide range of topics in basic and clinical neuro-oncology. Paediatric brain tumours, brain tumour biology, angiogenesis and brain edema, NMR spectroscopy, brain tumour imaging, prognostic factors in malignant glioma, new therapeutic approaches to malignant glioma, malignant glioma chemotherapy, treatment toxicity and management of metastasis were the major areas of focus at the meeting. In attendance were four outstanding guest speakers. Dr. Peter Berger, Professor of Pathology at Duke University Medical Centre, discussed the "Anatomy, Classification and Dedifferentiation of Astrocytic Neoplasms". Dr. Bengt Westermark, Professor of Tumour Biology at the University of Uppsala in Uppsala, Sweden, reviewed the current understanding of "Oncogenes and Growth Factors in Malignant Glioma". Dr. James Goldie, Professor of Medicine and Chief of Medical Oncology at the Cancer Control Agency of British Columbia, called upon extensive experience in solid tumour chemotherapy and developed "A Rational Approach to Malignant Glioma Chemotherapy". Dr. Clifford Schold, Associate Professor of Medicine (Neurology) at Duke University Medical Centre, emphasized the importance of methodology in his lecture entitled "Design and Conduct of Clinical Trials in Neuro-Oncology". The majority of participants were Canadian but there was a substantial American contribution to the 1988 meeting. Forty percent of papers were delivered by residents, fellows or graduate students. This reflects a substantial and growing interest in neurooncology in Canada. The 4th Canadian Neuro-Oncology Meeting will be held in Winnipeg in 1990 under the direction of Dr. D. Fewer.